セッション詳細
[WS(O)07]Macrophage 1
2024年12月3日(火) 14:00 〜 15:15
Room G
Organizers: Masako Kohyama (Center for Infectious Disease Education and Research (CiDER), Osaka University), Eiji Umemoto (School of Pharmaceutical Sciences, University of Shizuoka)
[WS07-04-O/P]The differential pyrin inflammasome responses between resident peritoneal and bone marrow-derived macrophages
○Izumi Sasaki1, Shiori Kaji2, Yuri Fukuda-Ohta1, Daisuke Okuzaki3, Takashi Kato1, Tsuneyasu Kaisho1 (1.Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, 2.Second Department of Internal Medicine, Wakayama Medical University, 3.WPI-Immunology Frontier Research Center, Osaka University)
[WS07-05-O/P]Clathrin heavy chain: a regulatory key for NLRP3 inflammasome activation via endocytosis in macrophages
○HUNG HIEP HUYNH1, Eri Koike1, Masumi Shimizu1, Akihiko Yoshimura2, Rimpei Morita1 (1.Department of Microbiology and Immunology, Nippon Medical School, 2.Graduate School of Medicine, Keio University)
[WS07-08-O/P]TAK1-binding protein 2 (TAB2) suppresses aberrant activation of NLRP3 inflammasome mediated by autocrine TNF-α
○Giichi Takaesu1,2,3, Tanveer Ali2, Goro Matsuzaki1,2,3 (1.Tropical Biosphere Research Center, University of the Ryukyus, 2.Department of Host Defense, Graduate School of Medicine, University of the Ryukyus, 3.Advanced Medical Research Center, University of the Ryukyus)
[WS07-10-O/P]A critical role of protein cross-linking enzyme transglutaminase 2 in M2 macrophage polarization and fibrosis
○Hideki Tatsukawa, Kiyotaka Hitomi (Graduate School of Pharmaceutical Sciences, Nagoya University)
[WS07-11-O/P]Autologous Macrophages induced by IL-34-based condition Suppress Hepatic Fibrosis with CD8+ T Cell Inhibition
○Yuichi Igarashi, Haruka Wada, Ken-ichiro Seino (Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University.)
[WS07-12-O/P]Dual-wield pathway of macrophages drives myofibroblast transition via dysregulation of iron metabolism
○Hiroshi Nabeshima1,2, Kiyoharu Fukushima2,3,4, Shizuo Akira2,3,5 (1.Host Defense Laboratory, Immunology Unit, Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., 2.Laboratory of Host Defense, World Premier Institute Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3.Department of Host Defense, Research Institute for Microbial Diseases (RIMD), Osaka University, 4.Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, 5.Center for Advanced Modalities and DDS (CAMaD), Osaka University)